 |
Dr. Jacob Teitelbaum's Column...expert advice on CFS, Fibromyalgia and other Health Topics. |
Jacob Teitelbaum MD is Medical Director of the Fibromyalgia and Fatigue Centers
(www.fibroandfatigue.com). Senior author of the landmark studies "Effective Treatment of Chronic Fatigue Syndrome and Fibromyalgia -- a Placebo-controlled Study" & "Effective Treatment of CFS & Fibromyalgia with D-Ribose". Author of the best-selling book "From Fatigued to Fantastic!"(3rd ed-Penguin/Avery Oct 4, 2007) , "Three Steps to Happiness! Healing through Joy", and "Pain Free 1-2-3- A Proven Program to Get YOU Pain Free!" (McGraw Hill, 2006). He does numerous media appearances, including CNN and FOX National News and is a frequent guest on Oprah and Friends with Dr. Oz.. He lives in Kona, Hawaii. Visit his web site at www.Vitality101.com
You can benefit from Dr. Teitelbaum's wisdom and experience by visiting us at The Environmental Illness Resource regularly to read articles from his latest newsletter!
Monday, January 23rd, 2012:
Treating Autism with NAET
by Jacob Teitelbaum MD
Dear Readers,
Our study has been accepted and the news is out. Effective treatment for autistic disorders is available with NAET!
Have you been feeling hopeless as your child struggles with autism? Been told by your physician that there is nothing that you can do, or been trying to sort through dozens of cures on the Internet? As a parent, trying to help an autistic child can be a difficult and scary struggle. The good news? There is now help and hope. New research suggests that it is time to say goodbye to autism!
Study Abstract — NAET Effective for Autism
Jacob Teitelbaum, M.D.1, Devi S. Nambudripad, M.D., Ph.D., D.C., L.Ac.2, Yvonne Tyson, M.D.3, Ming Chen, M.D.4, Robert Prince, M.D.5, Mala M. Moosad, R.N., L.Ac., Ph.D.6, Laurie Teitelbaum M.S.7 This study was accepted by the IMCJ and is "in press" pending publication.
Background
Autism prevalence increased by over 50% between 2002 and 2006. We hypothesized that major contributors to the development and symptoms of autism include food and nutrient sensitivities. Desensitization to multiple allergens forms the basis of the NAET treatment for autism.
Methods
Subjects & Intervention: Sixty children (2.5-10 years old) with a diagnosis of autism were randomly assigned to either the treatment or control groups. The treatment group consisted of 26 boys and 4 girls and the control group included 25 boys and 5 girls. The treatment group (30 children) received NAET treatments (combining acupressure and kinesiology) for 50 key allergens for 1 year. The children in the (non-blinded) control group did not receive any NAET treatments. Each group was allowed to continue with any other therapies they had been receiving. The NST (kinesiology/muscle testing) was used to determine which substances triggered sensitivity reactions in each child and NAET acupressure treatments were then used to eliminate the sensitivities.
Outcome Measures
The primary outcome measure was the Autism Research Institute Autism Treatment Evaluation Checklist (ARI-ATEC). Secondary outcome measures included the Childhood Autism Rating Scale (CARS), Neuromuscular Sensitivity Testing (NST) and the Allergy Symptom Rating Scale (ASRS). The participating children were evaluated using these instruments at the beginning and at the end of the 1-year study.
Results
56 children (26 in the NAET-treated group and 30 in the control group) completed the study. After one year, the children receiving NAET treatments exhibited clinically dramatic and statistically significant improvements in performance compared to the control group, as demonstrated by the mean 68.4% decrease in the total ARI-ATEC Score (compared to the mean 0.8% decrease in the control group; p<0.0001) and the 64% to 82% mean decreases on the 4 ARI-ATEC subtests (all p<0.0001). Similarly, the CARS rating improved by an average of 47.4% among the NAET-treated children, compared to only 0.4% in the control group (p<0.0001); the NST Score improved by an average of 65.5%, compared to a mean improvement of 0.0% (p<0.0001); and the total ASRS Score decreased by an average of 85%, compared to 2.3% (p<0.0001). In addition, NAET treatment also produced statistically significant improvements in each of 30 of the 35 symptoms assessed using the ASRS. Clinically, 23 of the 30 children in the treatment group were able to return to regular school classes with their healthy, non-autistic peers after treatment while all of the children in the control group continued to require special education.
Conclusions
NAET is an effective and well tolerated treatment for children with allergy-related autism.
Trial registration
ClinicalTrials.gov Registration # NCT00247156
1. Director of Kona Research Center
2. Director for Research, NAR Foundation Research Center, 6714-36 Beach Blvd, Buena Park, CA 90621
3. Assistant Director for Research, NAR Foundation Research Center, 6714-36 Beach Blvd., Buena Park, CA 90621.
4. Pediatrics, Synergy Integrated Healing Arts, San Gabriel, CA.
5. NAET of Carolina, Charlotte, NC
6. Clinical Director, NAR Foundation Research Center, 6714-36 Beach Blvd., Buena Park, CA 90621.
7. Co- Director, Kona Research Center.
Used with permission from Dr Jacob Teitelbaum's free newsletters-available at www.Vitality101.com
Learn more from Dr. Teitelbaum's books:
 |
From Fatigued to Fantastic!: A Proven Program to Regain Vibrant Health, Based on a New Scientific Study Showing Effective Treatment for Chronic Fatigue and Fibromyalgia |
 |
Pain Free 1-2-3: A Proven Program for Eliminating Chronic Pain Now! |
Related Articles:
